recomBead Treponema

Luminex®-based immunoassays (MagPlex®) for the detection of IgG or IgM antibodies
against Treponema pallidum in human serum and plasma

The Mikrogen recomBead Treponema tests are qualitative immunoassays, using recombinantly produced antigens, for the detection of IgG or IgM antibodies against Treponema pallidum. They allow a flexible combination of the advantages of ELISA and confirmatory testing on one plate. Based on recombinantly produced antigens, they can be used as a confirmatory test for Treponema infection, just like the immunoblot.

Products

Reagents for 96 determinations
Article no.: 5154 Request
Reagents for 96 determinations
Article no.: 5155 Request

Advantages

  • Reliable screening by immunodominant antigens produced by recombinant techniques:

Recombinant antigen

Function

Size [kDa]

Tp47 Membrane protein 47
TmpA Membrane protein 42
Tp257 (Gpd) Glycerophosphodiester phosphodiesterase, Membrane protein 39
Tp453 Membrane protein 28
Tp17 Membrane protein 17
Tp15 Membrane protein 15
  • Single antigens immobilized on differentiable, color-coded microparticles (beads)
  • Minimal cross-reactivity
  • Low sample volume sufficient (10 µl)
  • Very high measurement accuracy and reproducibility of test results
  • Ideally suited for high sample throughput
  • Fully automated processing, software-based evaluation (recomQuant) and connection to the laboratory information system possible

Safe and reliable

Validity check by integrated controls (incubation, conjugate and negative control)

Flexible and compatible

Combination of all Mikrogen recomBead immunoassays possible on one plate - uniform processing and interchangeable reagents

High Standard

CE mark: The recomBead Treponema tests meet the high requirements of the EC Directive 98/79/EC for in vitro diagnostic medical devices